Drug Research
FDA Searching For Ways To Support Customised Gene Therapy
Peter Marks, a top official at the Food and Drug Administration, is not tasked with determining if the expense of the medicines his teams are reviewing is justifiable. However, he is concerned that if businesses can't figure out how...
Drug Research
Merck-Moderna Sign Cancer Vaccine Deal Worth $250 Million
On October 12, 2022, Moderna revealed that Merck, also known as MSD outside of the US and Canada, had chosen to use its $250 million alternative to jointly create and distribute the PCV mRNA-4157/V940. The vaccine is now being...
Drug Research
Inflation Spurs Pharmaceuticals To Focus On Sustainability
Late in September, the trade group Medicines for Europe wrote an open letter to the European Commission (EC) requesting that the pharmaceutical sector be exempt from the EU's efforts to reduce gas usage. The group stated that such regulations...
Drug Research
Pfizer And Moderna Omicron Kid Boosters Approved By FDA
Following a decision by the Food and Drug Administration to broaden its authorization of reformulated shots from Moderna and partners Pfizer and BioNTech, kids as young as 5 years old can now receive an updated COVID-19 booster. The vaccine...
Drug Research
Stanford Scientists Devise A Breakthrough Cancer Treatment
The molecule tigilanol tiglate, also known as EBC-46, could provide tailored treatment for diseases including cancer, as according research from Stanford University in the US that was recently published in the scientific journal Nature Chemistry.
The chemical is only naturally...
Drug Research
Collaboration Between Ziphius and UZ Ghent on Vaccination
A public-private partnership between UZ Ghent and Ziphius Vaccines, a firm producing vaccines and treatments based on self-amplifying RNA (saRNA), has been announced. The collaboration entails scaling up and producing prophylactic self-amplifying RNA vaccines in accordance with GMP guidelines.
The...
Drug Research
The User Fees Have Been Authorised Yet Again At The FDA
As anticipated, four important user fee programmes were renewed by Congress for the week ending October 1st as part of a bill that was required to pass in order to finance the government for yet another two months. By...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.